Skip to content

A Clinical Comparison of Three Soft Daily Disposable Contact Lenses

A Clinical Comparison of Three Soft Daily Disposable Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02920983
Enrollment
51
Registered
2016-09-30
Start date
2016-09-30
Completion date
2017-02-28
Last updated
2019-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This study aims to compare the clinical performance of the somfilcon A, nelfilcon A II 2 and omafilcon A II 2 daily disposable contact lenses.

Detailed description

This will be a randomised, subject-masked, crossover, bilateral study, controlled by cross comparison. Fifty subjects will use each lens type for a week in random sequence. Follow-up visits for each lens will be performed after one week of wear. Lenses will be worn on a daily wear, daily disposable wear schedule.

Interventions

contact lens

DEVICEnelfilcon A II 2

contact lens

DEVICEomafilcon A ll 2

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects will only be eligible for the study if: 1. They are of legal age (18) and capacity to volunteer. 2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They agree not to participate in other clinical research for the duration of this study. 5. They have a contact lens spherical prescription between -1.00 to - 6.00D (Diopters) (inclusive) 6. They have a spectacle cylindrical correction of -0.75D or less in each eye. 7. At dispensing, they can attain at least 0.10 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range. 8. They currently use soft contact lenses or have done so in the previous six months. 9. They are willing to comply with the wear schedule (at least five days per week and for at least eight hours per day).

Exclusion criteria

* Subjects will not be eligible to take part in the study if: 1. They have an ocular disorder which would normally contra-indicate contact lens wear. 2. They have a systemic disorder which would normally contra-indicate contact lens wear. 3. They are using any topical medication such as eye drops or ointment. 4. They have had cataract surgery. 5. They have had corneal refractive surgery. 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 7. They are pregnant or breast-feeding. 8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. 9. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction. 10. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
Ocular Physiology1 weekOcular physiology assessment of by biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).

Secondary

MeasureTime frameDescription
Lens Fit - Vertical Centration1 weekVertical centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.
Lens Fit - Corneal Coverage1 weekCorneal coverage will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.
Lens Fit - Movement1 weekLens movement assessed using the following evaluations: extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive.
Lens Fit - Horizontal Centration1 weekHorizontal centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal.
Lens Surface - Wettability1 weekLens wettability will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe
Visual Acuity1 weekVisual acuity will be assessed by LogMAR.
Lens Surface - Deposition1 weekLens surface will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe

Countries

United Kingdom

Participant flow

Recruitment details

55 subjects were recruited for the study, 51 subjects were enrolled and 50 subjects completed the initial follow up visit.

Pre-assignment details

Subjects are randomized to wear each lens brand for one week in a random sequence.

Participants by arm

ArmCount
Overall Study
Total participants
55
Total55

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Dispense 1Unacceptable Lens Fit000010
Dispense 2Unscceptable lens fit100010
Dispense 3Unacceptable Lens Fit110010

Baseline characteristics

CharacteristicOverall Study
Age, Continuous35.6 years
STANDARD_DEVIATION 12.9
Sex: Female, Male
Female
35 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 480 / 49
other
Total, other adverse events
4 / 493 / 484 / 49
serious
Total, serious adverse events
0 / 490 / 480 / 49

Outcome results

Primary

Ocular Physiology

Ocular physiology assessment of by biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon AOcular PhysiologyPaipliiary Conjunctivitis0.95 units on a scaleStandard Deviation 0.28
Somofilcon AOcular PhysiologyConjunctival Hyperemia0.76 units on a scaleStandard Deviation 0.26
Somofilcon AOcular PhysiologyMicrocysts0.00 units on a scaleStandard Deviation 0
Somofilcon AOcular PhysiologyConjunctival Staining1.37 units on a scaleStandard Deviation 0.65
Somofilcon AOcular PhysiologyLimbal Hyperaemia0.63 units on a scaleStandard Deviation 0.24
Somofilcon AOcular PhysiologyOedema0.00 units on a scaleStandard Deviation 0
Somofilcon AOcular PhysiologyCorneal Vascularization0.05 units on a scaleStandard Deviation 0.11
Somofilcon AOcular PhysiologyCorneal Staining0.33 units on a scaleStandard Deviation 0.42
Nelfilcon A II 2Ocular PhysiologyLimbal Hyperaemia0.66 units on a scaleStandard Deviation 0.3
Nelfilcon A II 2Ocular PhysiologyConjunctival Hyperemia0.79 units on a scaleStandard Deviation 0.31
Nelfilcon A II 2Ocular PhysiologyConjunctival Staining0.41 units on a scaleStandard Deviation 0.43
Nelfilcon A II 2Ocular PhysiologyPaipliiary Conjunctivitis0.88 units on a scaleStandard Deviation 0.35
Nelfilcon A II 2Ocular PhysiologyCorneal Staining0.42 units on a scaleStandard Deviation 0.43
Nelfilcon A II 2Ocular PhysiologyCorneal Vascularization0.05 units on a scaleStandard Deviation 0.1
Nelfilcon A II 2Ocular PhysiologyMicrocysts0.00 units on a scaleStandard Deviation 0
Nelfilcon A II 2Ocular PhysiologyOedema0.00 units on a scaleStandard Deviation 0
Omafilcon A ll 2Ocular PhysiologyPaipliiary Conjunctivitis0.93 units on a scaleStandard Deviation 0.34
Omafilcon A ll 2Ocular PhysiologyConjunctival Hyperemia0.78 units on a scaleStandard Deviation 0.28
Omafilcon A ll 2Ocular PhysiologyLimbal Hyperaemia0.65 units on a scaleStandard Deviation 0.28
Omafilcon A ll 2Ocular PhysiologyCorneal Vascularization0.06 units on a scaleStandard Deviation 0.09
Omafilcon A ll 2Ocular PhysiologyMicrocysts0.00 units on a scaleStandard Deviation 0
Omafilcon A ll 2Ocular PhysiologyOedema0.00 units on a scaleStandard Deviation 0
Omafilcon A ll 2Ocular PhysiologyCorneal Staining0.26 units on a scaleStandard Deviation 0.36
Omafilcon A ll 2Ocular PhysiologyConjunctival Staining0.23 units on a scaleStandard Deviation 0.2
Secondary

Lens Fit - Corneal Coverage

Corneal coverage will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Fit - Corneal CoverageSlightly Temporal0 Participants
Somofilcon ALens Fit - Corneal CoverageOptimum46 Participants
Somofilcon ALens Fit - Corneal CoverageExtremely Nasal0 Participants
Somofilcon ALens Fit - Corneal CoverageSlightly Nasal3 Participants
Somofilcon ALens Fit - Corneal CoverageExtremely Temporal0 Participants
Nelfilcon A II 2Lens Fit - Corneal CoverageOptimum39 Participants
Nelfilcon A II 2Lens Fit - Corneal CoverageExtremely Nasal0 Participants
Nelfilcon A II 2Lens Fit - Corneal CoverageSlightly Nasal7 Participants
Nelfilcon A II 2Lens Fit - Corneal CoverageSlightly Temporal2 Participants
Nelfilcon A II 2Lens Fit - Corneal CoverageExtremely Temporal0 Participants
Omafilcon A ll 2Lens Fit - Corneal CoverageExtremely Temporal0 Participants
Omafilcon A ll 2Lens Fit - Corneal CoverageSlightly Temporal4 Participants
Omafilcon A ll 2Lens Fit - Corneal CoverageExtremely Nasal0 Participants
Omafilcon A ll 2Lens Fit - Corneal CoverageOptimum41 Participants
Omafilcon A ll 2Lens Fit - Corneal CoverageSlightly Nasal4 Participants
Secondary

Lens Fit - Horizontal Centration

Horizontal centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal.

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Fit - Horizontal CentrationSlightly Temporal20 Participants
Somofilcon ALens Fit - Horizontal CentrationOptimum28 Participants
Somofilcon ALens Fit - Horizontal CentrationExtremely Nasal0 Participants
Somofilcon ALens Fit - Horizontal CentrationSlightly Nasal1 Participants
Somofilcon ALens Fit - Horizontal CentrationExtremely Temporal0 Participants
Nelfilcon A II 2Lens Fit - Horizontal CentrationOptimum28 Participants
Nelfilcon A II 2Lens Fit - Horizontal CentrationExtremely Nasal0 Participants
Nelfilcon A II 2Lens Fit - Horizontal CentrationSlightly Nasal3 Participants
Nelfilcon A II 2Lens Fit - Horizontal CentrationSlightly Temporal17 Participants
Nelfilcon A II 2Lens Fit - Horizontal CentrationExtremely Temporal0 Participants
Omafilcon A ll 2Lens Fit - Horizontal CentrationExtremely Temporal0 Participants
Omafilcon A ll 2Lens Fit - Horizontal CentrationSlightly Temporal22 Participants
Omafilcon A ll 2Lens Fit - Horizontal CentrationExtremely Nasal0 Participants
Omafilcon A ll 2Lens Fit - Horizontal CentrationOptimum26 Participants
Omafilcon A ll 2Lens Fit - Horizontal CentrationSlightly Nasal1 Participants
Secondary

Lens Fit - Movement

Lens movement assessed using the following evaluations: extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive.

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Fit - MovementSlightly excessive8 Participants
Somofilcon ALens Fit - MovementOptimum38 Participants
Somofilcon ALens Fit - MovementExtremely inadequate0 Participants
Somofilcon ALens Fit - MovementSlightly inadequate3 Participants
Somofilcon ALens Fit - MovementExtremely excessive0 Participants
Nelfilcon A II 2Lens Fit - MovementOptimum27 Participants
Nelfilcon A II 2Lens Fit - MovementExtremely inadequate0 Participants
Nelfilcon A II 2Lens Fit - MovementSlightly inadequate19 Participants
Nelfilcon A II 2Lens Fit - MovementSlightly excessive2 Participants
Nelfilcon A II 2Lens Fit - MovementExtremely excessive0 Participants
Omafilcon A ll 2Lens Fit - MovementExtremely excessive1 Participants
Omafilcon A ll 2Lens Fit - MovementSlightly excessive9 Participants
Omafilcon A ll 2Lens Fit - MovementExtremely inadequate0 Participants
Omafilcon A ll 2Lens Fit - MovementOptimum27 Participants
Omafilcon A ll 2Lens Fit - MovementSlightly inadequate12 Participants
Secondary

Lens Fit - Vertical Centration

Vertical centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Fit - Vertical CentrationOptimum21 Participants
Somofilcon ALens Fit - Vertical CentrationExtremely Nasal0 Participants
Somofilcon ALens Fit - Vertical CentrationExtremely Temporal0 Participants
Somofilcon ALens Fit - Vertical CentrationSlightly Nasal11 Participants
Somofilcon ALens Fit - Vertical CentrationSlightly Temporal17 Participants
Nelfilcon A II 2Lens Fit - Vertical CentrationExtremely Nasal0 Participants
Nelfilcon A II 2Lens Fit - Vertical CentrationOptimum22 Participants
Nelfilcon A II 2Lens Fit - Vertical CentrationSlightly Temporal6 Participants
Nelfilcon A II 2Lens Fit - Vertical CentrationExtremely Temporal0 Participants
Nelfilcon A II 2Lens Fit - Vertical CentrationSlightly Nasal20 Participants
Omafilcon A ll 2Lens Fit - Vertical CentrationExtremely Temporal0 Participants
Omafilcon A ll 2Lens Fit - Vertical CentrationExtremely Nasal0 Participants
Omafilcon A ll 2Lens Fit - Vertical CentrationSlightly Nasal22 Participants
Omafilcon A ll 2Lens Fit - Vertical CentrationOptimum22 Participants
Omafilcon A ll 2Lens Fit - Vertical CentrationSlightly Temporal5 Participants
Secondary

Lens Surface - Deposition

Lens surface will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Surface - DepositionGrade 30 Participants
Somofilcon ALens Surface - DepositionGrade 20 Participants
Somofilcon ALens Surface - DepositionGrade 046 Participants
Somofilcon ALens Surface - DepositionGrade 13 Participants
Somofilcon ALens Surface - DepositionGrade 40 Participants
Nelfilcon A II 2Lens Surface - DepositionGrade 20 Participants
Nelfilcon A II 2Lens Surface - DepositionGrade 047 Participants
Nelfilcon A II 2Lens Surface - DepositionGrade 11 Participants
Nelfilcon A II 2Lens Surface - DepositionGrade 30 Participants
Nelfilcon A II 2Lens Surface - DepositionGrade 40 Participants
Omafilcon A ll 2Lens Surface - DepositionGrade 40 Participants
Omafilcon A ll 2Lens Surface - DepositionGrade 30 Participants
Omafilcon A ll 2Lens Surface - DepositionGrade 048 Participants
Omafilcon A ll 2Lens Surface - DepositionGrade 20 Participants
Omafilcon A ll 2Lens Surface - DepositionGrade 11 Participants
Secondary

Lens Surface - Wettability

Lens wettability will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Somofilcon ALens Surface - WettabilityGrade 30 Participants
Somofilcon ALens Surface - WettabilityGrade 23 Participants
Somofilcon ALens Surface - WettabilityGrade 037 Participants
Somofilcon ALens Surface - WettabilityGrade 19 Participants
Somofilcon ALens Surface - WettabilityGrade 40 Participants
Nelfilcon A II 2Lens Surface - WettabilityGrade 21 Participants
Nelfilcon A II 2Lens Surface - WettabilityGrade 044 Participants
Nelfilcon A II 2Lens Surface - WettabilityGrade 13 Participants
Nelfilcon A II 2Lens Surface - WettabilityGrade 30 Participants
Nelfilcon A II 2Lens Surface - WettabilityGrade 40 Participants
Omafilcon A ll 2Lens Surface - WettabilityGrade 40 Participants
Omafilcon A ll 2Lens Surface - WettabilityGrade 30 Participants
Omafilcon A ll 2Lens Surface - WettabilityGrade 043 Participants
Omafilcon A ll 2Lens Surface - WettabilityGrade 23 Participants
Omafilcon A ll 2Lens Surface - WettabilityGrade 13 Participants
Secondary

Visual Acuity

Visual acuity will be assessed by LogMAR.

Time frame: 1 week

Population: Protocol deviations and discontinuations account for difference in analysis population

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon AVisual AcuityLow Contrast0.18 LogMARStandard Deviation 0.1
Somofilcon AVisual AcuityHigh Contrast-0.11 LogMARStandard Deviation 0.08
Nelfilcon A II 2Visual AcuityLow Contrast0.17 LogMARStandard Deviation 0.11
Nelfilcon A II 2Visual AcuityHigh Contrast-0.13 LogMARStandard Deviation 0.08
Omafilcon A ll 2Visual AcuityLow Contrast0.18 LogMARStandard Deviation 0.1
Omafilcon A ll 2Visual AcuityHigh Contrast-0.11 LogMARStandard Deviation 0.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026